Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check7 days agoChange DetectedA banner announces an NIH terminology transition, saying that agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and related navigation with a blocked-access screen; this prevents viewing the study details on this page.SummaryDifference18%

- Check63 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a backend/software update with no substantive content changes.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor version update to the page or its documentation. The change does not reveal any user-facing content changes.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.